NCT05884242: A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge |
|
|
| Completed | 1 | 20 | Europe | Adalimumab, Humira, Lipopolysaccharide (LPS) | Janssen Research & Development, LLC | Healthy | 08/23 | 08/23 | | |
| Not yet recruiting | 1 | 30 | Europe | Adalimumab-800CW, Humira, Fluorescence Imaging | University Medical Center Groningen, AbbVie | IBD, Rheumatoid Arthritis | 06/24 | 12/24 | | |